Literature DB >> 8941926

ELK and LERK-2 in developing kidney and microvascular endothelial assembly.

T O Daniel1, E Stein, D P Cerretti, P L St John, B Robert, D R Abrahamson.   

Abstract

Eph family receptor tyrosine kinases direct neuronal cell targeting, bundling and intercellular aggregation activity, yet their role in mammalian kidney development has been unexplored to date. We recently identified expression of ELK (Eph-like kinase) receptors in cultured human renal microvascular endothelial cells (HRMEC), and showed that ELK mediates their in vitro assembly into capillary-like structures in response to the exogenous ligand, LERK-2. Here we identify expression of the ELK ligand, LERK-2, in HRMEC and in primitive vascular structures of developing murine kidney. ELK and LERK-2 are expressed on endothelial progenitor cells of primitive microvasculature in a pattern similar to that of the VEGF receptor, flk-1. ELK LERK-2 and flk-1 antigens are also displayed on the branching ureteric bud epithelium; ELK and LERK-2 expression persists in mature collecting ducts, glomeruli and arterioles. To explore whether renal-derived endothelial cells may distinguish LERK-2 from the angiogenic Eck ligand, LERK-1 (B61), and whether endothelial cells from different sources may distinguish among Eph receptor ligands, we compared HRMEC and human umbilical vein endothelial cell (HUVEC) responses in an in vitro capillary-like assembly assay. HRMEC endothelial cells assembled capillary-like structures in response to LERK-2, but not LERK-1, under conditions that promoted HUVEC to assemble in response to LERK-1, but not LERK-2. Therefore, responses mediated through specific Eph family receptors (ELK and Eck) are discriminated by endothelial cells from different vascular bed sources. ELK and its ligand, LERK-2, are spatially and temporally coordinated in expression and may function in morphogenesis of the renal microvasculature.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8941926

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  22 in total

1.  Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues.

Authors:  Amy L McDoniels-Silvers; Gary D Stoner; Ronald A Lubet; Ming You
Journal:  Neoplasia       Date:  2002 Mar-Apr       Impact factor: 5.715

2.  Biomimetic hydrogels with immobilized ephrinA1 for therapeutic angiogenesis.

Authors:  Jennifer E Saik; Daniel J Gould; Aakash H Keswani; Mary E Dickinson; Jennifer L West
Journal:  Biomacromolecules       Date:  2011-06-15       Impact factor: 6.988

3.  A microarray analysis of angiogenesis modulation effect of Xuefu Zhuyu Decoction on endothelial cells.

Authors:  Jun Song; Wen-Yuan Chen; Li-Ya Wu; Liang-Pu Zheng; Wei Lin; Dong Gao; Ted J Kaptchuk; Ke-Ji Chen
Journal:  Chin J Integr Med       Date:  2012-07-07       Impact factor: 1.978

4.  Proangiogenic role of ephrinB1/EphB1 in basic fibroblast growth factor-induced corneal angiogenesis.

Authors:  Takashi Kojima; Jin-Hong Chang; Dimitri T Azar
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 5.  Eph/ephrin signaling in the kidney and lower urinary tract.

Authors:  Anna-Carina Weiss; Andreas Kispert
Journal:  Pediatr Nephrol       Date:  2015-04-23       Impact factor: 3.714

6.  Development of kidney glomerular endothelial cells and their role in basement membrane assembly.

Authors:  Dale R Abrahamson
Journal:  Organogenesis       Date:  2009-01       Impact factor: 2.500

7.  Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis.

Authors:  Sonja G Hunter; Guanglei Zhuang; Dana Brantley-Sieders; Wojciech Swat; Christopher W Cowan; Jin Chen
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

8.  Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma.

Authors:  X X Tang; H Zhao; M E Robinson; B Cohen; A Cnaan; W London; S L Cohn; N K Cheung; G M Brodeur; A E Evans; N Ikegaki
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

9.  Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesis.

Authors:  Birgit Mosch; Bettina Reissenweber; Christin Neuber; Jens Pietzsch
Journal:  J Oncol       Date:  2010-03-10       Impact factor: 4.375

10.  Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor.

Authors:  J Wykosky; E Palma; D M Gibo; S Ringler; C P Turner; W Debinski
Journal:  Oncogene       Date:  2008-09-15       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.